Closing arguments heard in Fosamax/ONJ trial
No causal relationship between oral bisphosphonates and osteonecrosis of the jaw (ONJ) has been has been established, according to Christy Jones, attorney for Merck, during closing arguments February 10 in the Rosenberg v. Merck Fosamax trial. Allison Rosenberg, 67, says she used Fosamax from 1999 to 2006 and that she suffered various jaw problems and complications following a tooth extraction in December 2005. Merck has maintained that Fosamax did not

